- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05127343
Comparison Between Resin Based and Glass Ionomer Based Hydrophilic Fissure Sealants
November 12, 2021 updated by: Ghada Mohamed El-Amir Hashim Sediek, Cairo University
One Year Clinical Comparison Between Resin Based and Glass Ionomer Based Hydrophilic Fissure Sealants Among Adolescents: A Randomized Clinical Trial
The aim of the study is to clinically evaluate the retention and caries formation of hydrophilic fissure sealants among adolescents after one year.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Iman I ElSayad, Professor
- Phone Number: 0201005287368
- Email: iman.sayad@dentistry.cu.edu.eg
Study Contact Backup
- Name: Heba Helal, Post Phd
- Email: heba.helal@dentistry.cu.edu.eg
Study Locations
-
-
-
Cairo, Egypt, 11331
- Faculty of Dentistry
-
Contact:
- Iman I ElSayad, Professor
- Phone Number: 0201005287368
- Email: iman.sayad@dentistry.cu.edu.eg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 16 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients who have existing pits and fissures that are anatomically deep and caries susceptible.
- Healthy patients with no history of previous systematic diseases that can affect their oral health and sealant application.
- Cooperative patients who will allow the clinical applications
Exclusion Criteria:
- Uncooperative behaviour limiting the use of sealants throughout the procedure.
- Patients with history of medical diseases, drug therapies or any other serious relevant problem.
- Patients with well coalesced pits and fissures
- Patients allergic to sealant material
- Patients who underwent orthodontic treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Resin based sealant (Ultraseal XT Hydro)
|
Application of the pit and fissure sealant
|
|
Active Comparator: Glass ionomer based sealant (Fugi Triage)
|
Application of the pit and fissure sealant
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention rate
Time Frame: Change from baseline at 3, 6, 12 months
|
|
Change from baseline at 3, 6, 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caries formation
Time Frame: Change from baseline at 3, 6, 12 months
|
Decayed: If the explorer caught on the tooth after insertion into the fissures
|
Change from baseline at 3, 6, 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Iman I ElSayad, Professor, Cairo University
- Study Director: Heba Helal, Cairo University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
February 1, 2022
Primary Completion (Anticipated)
July 1, 2022
Study Completion (Anticipated)
February 1, 2023
Study Registration Dates
First Submitted
November 12, 2021
First Submitted That Met QC Criteria
November 12, 2021
First Posted (Actual)
November 19, 2021
Study Record Updates
Last Update Posted (Actual)
November 19, 2021
Last Update Submitted That Met QC Criteria
November 12, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- CU-2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.